Terms: = Germ cell tumor AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534
32 results:
1. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
Wong P; Wisneski AD; Tsai KK; Chang TT; Hirose K; Nakakura EK; Daud AI; Maker AV; Corvera CU
World J Surg Oncol; 2024 Mar; 22(1):77. PubMed ID: 38468341
[TBL] [Abstract] [Full Text] [Related]
2. CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.
Park JW; Kilic O; Deo M; Jimenez-Cowell K; Demirdizen E; Kim H; Turcan Ş
Acta Neuropathol Commun; 2023 Jan; 11(1):13. PubMed ID: 36647117
[TBL] [Abstract] [Full Text] [Related]
3. Disparities in quality of life, social distress and employment outcomes in Australian cancer survivors.
White VM; Lisy K; Ward A; Ristevski E; Clode M; Webber K; Emery J; Ijzerman MJ; Afshar N; Millar J; Gibbs P; Evans S; Jefford M
Support Care Cancer; 2022 Jun; 30(6):5299-5309. PubMed ID: 35279769
[TBL] [Abstract] [Full Text] [Related]
4. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.
Gordon K; Gulidov I; Koryakin S; Smyk D; Makeenkova T; Gogolin D; Lepilina O; Golovanova O; Semenov A; Dujenko S; Medvedeva K; Mardynsky Y
Radiat Oncol; 2021 Dec; 16(1):238. PubMed ID: 34930352
[TBL] [Abstract] [Full Text] [Related]
5. Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1.
Ferreira WAS; Amorim CKN; Burbano RR; Villacis RAR; Marchi FA; Medina TS; Lima MMC; Oliveira EHC
Braz J Med Biol Res; 2021; 54(3):e9571. PubMed ID: 33470396
[TBL] [Abstract] [Full Text] [Related]
6. Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study.
Adolph JE; Fleischhack G; Mikasch R; Zeller J; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S; Schüller U; von Hoff K; Obrecht D; Pietsch T; Pfister SM; Pajtler KW; Witt O; Witt H; Kortmann RD; Timmermann B; Krauß J; Frühwald MC; Faldum A; Kwiecien R; Bode U; Tippelt S
Neuro Oncol; 2021 Jun; 23(6):1012-1023. PubMed ID: 33331885
[TBL] [Abstract] [Full Text] [Related]
7. Frequent copy number gains of SLC2A3 and etv1 in testicular embryonal carcinomas.
Hoff AM; Kraggerud SM; Alagaratnam S; Berg KCG; Johannessen B; Høland M; Nilsen G; Lingjærde OC; Andrews PW; Lothe RA; Skotheim RI
Endocr Relat Cancer; 2020 Sep; 27(9):457-468. PubMed ID: 32580154
[TBL] [Abstract] [Full Text] [Related]
8. c-Src Phosphorylates and Inhibits the Function of the CIC tumor Suppressor Protein.
Bunda S; Heir P; Li ASC; Mamatjan Y; Zadeh G; Aldape K
Mol Cancer Res; 2020 May; 18(5):774-786. PubMed ID: 32029440
[TBL] [Abstract] [Full Text] [Related]
9. Biosynthetic CircRNA_001160 induced by PTBP1 regulates the permeability of BTB via the CircRNA_001160/miR-195-5p/etv1 axis.
Li H; Shen S; Ruan X; Liu X; Zheng J; Liu Y; Yang C; Wang D; Liu L; Ma J; Ma T; Wang P; Cai H; Li Z; Zhao L; Xue Y
Cell Death Dis; 2019 Dec; 10(12):960. PubMed ID: 31862871
[TBL] [Abstract] [Full Text] [Related]
10. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma tumorigenicity by Affecting Multiple cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract] [Full Text] [Related]
11. A novel PTPRZ1-etv1 fusion in gliomas.
Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
[TBL] [Abstract] [Full Text] [Related]
12. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, tumor Mutational Burden, and Hypermutation Signatures.
Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
[TBL] [Abstract] [Full Text] [Related]
14. Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence.
Baysan M; Woolard K; Cam MC; Zhang W; Song H; Kotliarova S; Balamatsias D; Linkous A; Ahn S; Walling J; Belova GI; Fine HA
Int J Cancer; 2017 Nov; 141(10):2002-2013. PubMed ID: 28710771
[TBL] [Abstract] [Full Text] [Related]
15. Circulating miR-128 as a potential diagnostic biomarker for glioma.
Liang RF; Li M; Yang Y; Wang X; Mao Q; Liu YH
Clin Neurol Neurosurg; 2017 Sep; 160():88-91. PubMed ID: 28704779
[TBL] [Abstract] [Full Text] [Related]
16. The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis.
Kollareddy M; Sherrard A; Park JH; Szemes M; Gallacher K; Melegh Z; Oltean S; Michaelis M; Cinatl J; Kaidi A; Malik K
Cancer Lett; 2017 Sep; 403():74-85. PubMed ID: 28602975
[TBL] [Abstract] [Full Text] [Related]
17. miR-17 regulates melanoma cell motility by inhibiting the translation of etv1.
Cohen R; Greenberg E; Nemlich Y; Schachter J; Markel G
Oncotarget; 2015 Aug; 6(22):19006-16. PubMed ID: 26158900
[TBL] [Abstract] [Full Text] [Related]
18. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.
Gleize V; Alentorn A; Connen de Kérillis L; Labussière M; Nadaradjane AA; Mundwiller E; Ottolenghi C; Mangesius S; Rahimian A; Ducray F; ; Mokhtari K; Villa C; Sanson M
Ann Neurol; 2015 Sep; 78(3):355-74. PubMed ID: 26017892
[TBL] [Abstract] [Full Text] [Related]
19. Expression of Kit and etv1 in restricted brain regions supports a brain-cell progenitor as an origin for cranial germinomas.
Tan C; Scotting P
Cancer Genet; 2015 Mar; 208(3):55-61. PubMed ID: 25736805
[TBL] [Abstract] [Full Text] [Related]
20. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
Labussière M; Di Stefano AL; Gleize V; Boisselier B; Giry M; Mangesius S; Bruno A; Paterra R; Marie Y; Rahimian A; Finocchiaro G; Houlston RS; Hoang-Xuan K; Idbaih A; Delattre JY; Mokhtari K; Sanson M
Br J Cancer; 2014 Nov; 111(10):2024-32. PubMed ID: 25314060
[TBL] [Abstract] [Full Text] [Related]
[Next]
